In a cohort of NSCLC resected patients, ALK positivity seemed to be associated with poor prognosis [47]; however, the outcomes of patients treated with chemotherapy were similar to those observed in EGFR wild-type population [43]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.